The New Zealand sharemarket slipped to a six-week low as investors sold blue-chip stocks Fisher and Paykel Healthcare and Ebos to help fund Fletcher Building’s big capital raise.

Fletcher Building’s eighth capital raising in two decades – this one for $700 million – weighed heavily on the New Zealand sharemarket, which fell more than 0.5%.

The New Zealand sharemarket declined nearly 1.5% as stock prices bounced wildly on index rebalancing despite a sharp rebound on Wall Street.

The trans-Tasman sharemarkets fared better than their American counterparts following the Federal Reserve's cut in “the jumbo interest rate”.

Synlait Milk can look forward to a brighter future, Spark hit a nine-year low and the New Zealand sharemarket posted its third successive fall.

The New Zealand sharemarket bided its time with a small fall as it waited for key economic events that will dictate the course of interest rate cuts.

Investors scrambled to raise money and participate in Auckland International Airport’s massive $1.4 billion capital raise which weighed on the New Zealand sharemarket.

The New Zealand sharemarket took an end-of-the-week breather after a strong start to the month, with leading blue-chip stocks coming off the boil.

The New Zealand sharemarket rebounded 1.5% to a 32-month high, led by the increasingly influential Fisher and Paykel Healthcare – with some corporate action in minnow stocks.

Energy generator Manawa surged more than 30% on the New Zealand sharemarket after receiving a takeover proposal from Contact valued at $1.86 billion and supported by major shareholders.

After dipping before midday, New Zealand shares closed marginally up on relatively high trading volumes despite a slow news Tuesday.

New Zealand shares bucked the trend across Asia as they edged higher, with Gentrack and Infratil among the leaders having been added to an Australian index, meaning passive investors will have to track the local companies.

New Zealand shares petered out ahead of US employment data seen as central to the Federal Reserve’s upcoming rate cuts, as Infratil and Fisher & Paykel Healthcare's lofty heights underpinned the weekly gain.

New Zealand shares climbed, and Infratil hit an all-time high as Australia’s A$24 billion (NZ$26b) AirTrunk deal stoked investors’ appetite for data centres.

New Zealand shares rose, outperforming Asian stock markets, as a slump in US chipmaker Nvidia weighed worldwide tech stocks, which aren’t a big feature on the local bourse.

New Zealand shares drifted lower as investors continued to digest the glut of information from earnings season and kept one eye on upcoming dividend payments.